Insider Transactions in Q4 2024 at Precision Biosciences Inc (DTIL)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
John Alexander Kelly Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+7.3%
|
$18,000
$6.76 P/Share
|
|
Nov 04
2024
|
Michael Amoroso President and CEO |
SELL
Open market or private sale
|
Direct |
3,012
-9.55%
|
$24,096
$8.19 P/Share
|
|
Nov 04
2024
|
Dario Scimeca General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
588
-6.87%
|
$4,704
$8.19 P/Share
|
|
Nov 02
2024
|
John Alexander Kelly Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,605
+9.32%
|
-
|
|
Nov 02
2024
|
Michael Amoroso President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,443
+23.04%
|
-
|
|
Nov 02
2024
|
Dario Scimeca General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,836
+17.67%
|
-
|